S3
Pain: the new paradigm
Has pharmacy moved on from the codeine upscheduling? Our panel talks about the new paradigm in pain management by pharmacists In the second of our podcasts on pain treatment and …
Paracetamol on the move
Modified release paracetamol upscheduled to S3, but GP groups express concern about the move Modified release paracetamol are set to be re-scheduled as S3 (Pharmacist Only) products according to the …
Pharmacist prescribing
It’s one of the hot topics in pharmacy and one that is very firmly on the agenda in 2019. We speak to a wide range of pharmacists – from academics, …
Keeping your hair on
Leading hair-loss treatment could be set to move to pharmacist-only category Regulators are set to decide on a request to down-schedule a leading hair-loss treatment to the S3 (Pharmacist Only) …
Getting the message out
Relaxed medicine advertising guidelines are set to boost downscheduling applications, industry believes Recent reforms to advertising regulations for Schedule 3 medicines are a “big win” for consumers, pharmacy and industry, …
Schedule change proposed for ED drug
New proposal put forward for Pharmacist-Only sildenafil category The TGA’s Advisory Committee on Medicines Scheduling is set to again review the possibility of creating an S3 category for sildenafil (Viagra). There …
Maxigesic takes the lead
Maxigesic is outselling other paracetamol-ibuprofen brands in pharmacy There has been strong sales in schedule 3 30s packs, which the company says is significant as it means pharmacists are recommending it …
A pain free transition
PDL takes a look at a challenging codeine customer situation From 1 February 2018 medicines containing codeine will no longer be available without a prescription due to the Therapeutic Goods …
Support for S3 ad restriction changes
The Australian Self Medication Industry has announced its support for the TGA’s commitment to change restrictions on the advertising of S3 medicines ASMI also says it supports the establishment of …
Direct to consumers
TGA’s surprise move to allow easier advertising of S3 medicines catches the industry and health professionals by surprise A new Scheduling Handbook, announced by the TGA late on Thursday (18th) …
Clash over S4 to S3 downscheduling
Doctors’s group disagrees with expansion of downscheduling S4 medicines with controls, citing patient safety concerns The Australian Medical Association (AMA) has again taken aim at pharmacy, this time over the …
Keeping them separate
Should all S2 and S3 medicines to be kept behind the counter, with a completely separate area for CMs? And who supports this proposition? Recently the Review of Pharmacy Remuneration …